Two years after submitting the latest version of its insulin pump technology for FDA approval—and three years after it was first made available in Europe—Medtronic has finally secured the agency’s ...

DUBLIN, June 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Marking of its MiniMed™ 780G system, a next ...

Medtronic has secured a new approval in Europe, greatly expanding the reach of its MiniMed 780G pump system—including for people with Type 2 diabetes who require insulin. The CE mark also opens it up ...

As Medtronic begins rolling out a recently FDA-cleared diabetes management system combining its MiniMed 780G insulin pump and Abbott’s Instinct glucose sensor, the medtech giant has launched a new ...

Add Yahoo as a preferred source to see more of our stories on Google. Medtronic has received 510(k) clearance for the use of its MiniMed 780G pump with two ultra-rapid-acting insulins and with a ...

Medtronic plc MDT recently announced the receipt of the CE Mark for its next generation closed loop insulin pump system, MiniMed 780G, for the treatment of type 1 diabetes in the age range of 7 to 80 ...

Wide-moat Medtronic received highly welcome news today as the U.S. Food and Drug Administration has (finally) approved the firm’s next-gen 780g insulin pump, and we’re leaving our $112 fair value ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...

Medtronic has announced that its long-awaited 780G diabetic therapy system has gained FDA approval which includes support for iPhone and Apple Watch monitoring. The Medtronic 780G system encompasses ...

Medtronic kicked off Diabetes Awareness Month with news that its MiniMed 780G system for people living with type 1 diabetes has received a regulatory license from Health Canada. The company touts that ...

Medtronic says it has promising data on the effectiveness of its next-generation insulin pump from patients in Europe and Chile. The MiniMed 780G insulin pump, which was cleared in 2020 for use in ...